Back to Wells Fargo & Company Wells Fargo & Company

AGRXAGRX

Showing 0 of 4 quarters

Position history for Wells Fargo & CompanyWells Fargo & Company's holdings in AGILE THERAPEUTICS INC

No. Wells Fargo exited its AGRX (Agile Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 19 shares worth $37. Wells Fargo first reported AGRX in Q2 2023 and held it in 3 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

—

No position history available for this security.

Optional analytics helps us improve. How it’s used